Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 11—November 2012

Letter

Seroprevalence of Pandemic Influenza Viruses, New York, New York, USA, 2004

Isaac B. Weisfuse, Tshidi Tsibane, Kevin J. KontyComments to Author , Joseph R. Egger1, Elizabeth Needham Waddell, Saad Rahmat, Emily Harris, Donald R. Olson, and Christopher F. Basler
Author affiliations: New York City Department of Health and Mental Hygiene, New York, New York, USA (I.B. Weisfuse, K.J. Konty, J.R. Egger, E.N. Wadell, D.R. Olson); Mount Sinai School of Medicine, New York (T. Tsibane, S. Rahmat, E. Harris, C.F. Basler); and International Society for Disease Surveillance, New York, (D.R. Olson)

Main Article

Figure

Seroprevalence of cross-reactive antibodies to the 1918, 1957, 1968, and 2009 pandemic influenza viruses among persons >23 years of age, New York, New York, 2004. LOESS (locally weighted scatterplot smoothing) curves represent the estimated prevalence of hemagglutination-inhibition antibody titers of >40 (positive titers) by year of birth.

Figure. Seroprevalence of cross-reactive antibodies to the 1918, 1957, 1968, and 2009 pandemic influenza viruses among persons >23 years of age, New York, New York, 2004. LOESS (locally weighted scatterplot smoothing) curves represent the estimated prevalence of hemagglutination-inhibition antibody titers of >40 (positive titers) by year of birth.

Main Article

1Current affiliation: SciMetrika, LLC, Research Triangle Park, North Carolina, USA.

TOP